Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral Crystallization Resolution. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN104781243A details a novel chiral synthesis for ribonolactone intermediates. This report analyzes cost reduction and supply chain advantages for pharmaceutical manufacturing.
Patent CN114163411A details a scalable crystallization resolution method for dihydromyricetin offering significant cost reduction and supply chain reliability for global pharmaceutical manufacturers.